Skip to content

California · Nonprofit

HIRSHBERG FOUNDATION FOR PANCREATIC CANC

HIRSHBERG FOUNDATION FOR PANCREATIC CANC (California) receives grants from 83 organizations whose IRS filings report $3,284,603 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($947,060). 32 of them have funded it in more than one year, and 59% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2024
$2.8M
Funders on record
83
Grants received
$3.3M
Net assets
$3.1M
32/83 repeat funderspeak grant-dependency 17%
01What it does

What Hirshberg Foundation for Pancreatic Canc does

Mission

Founded in 1997, the Hirshberg Foundation for Pancreatic Cancer research is a national, nonprofit organization dedicated to advancing pancreatic cancer research, and providing information, resources, and support to pancreatic cancer patients and their families.

As stated on its FY2024 Form 990.

Programs

  1. The research programs include various grants and commitments to further research into finding a cure for pancreatic cancer. Through our seed grant program we support basic and clinical scientists and investigators in the u.s. And abroad, awarding more than 130 grants since 2005 and funding more than 50 medical research institutions globally. The ucla agi hirshberg center for pancreatic diseases provides a critical hub for advancing research and treatment breakthroughs. We fund 3 laboratories at ucla focusing on basic and translational science. We fund a pancreas tissue bank.

    $1,801,492 spentof which $1,574,736 as grants
    83% of program spending
  2. The patient support programs provide information and guidance to patients and caregivers, including counseling and support groups, alternative medicine, clinical trial updates, patient advocacy, financial aid and genetic counseling. Our annual symposium is a patient centered education program that has integrated nearly 200 researchers, clinicians, patients and families to learn about developments, treatments and progression of finding a cure. Our patient and family webinar series is an interactive series connecting specialists with the pancreatic cancer community.

    $360,103 spent
    17% of program spending

The 2 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $2,161,595.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($1.8M) Expenses 100 ($1.7M) Net assets 100 ($1.5M)2018 Revenue 99 ($1.8M) Expenses 84 ($1.4M) Net assets 127 ($2.0M)2019 Revenue 109 ($2.0M) Expenses 72 ($1.2M) Net assets 179 ($2.7M)2020 Revenue 89 ($1.6M) Expenses 72 ($1.2M) Net assets 207 ($3.2M)2021 Revenue 120 ($2.2M) Expenses 92 ($1.5M) Net assets 251 ($3.9M)2022 Revenue 132 ($2.4M) Expenses 159 ($2.6M) Net assets 198 ($3.0M)2023 Revenue 155 ($2.8M) Expenses 183 ($3.1M) Net assets 209 ($3.2M)2024 Revenue 152 ($2.8M) Expenses 184 ($3.1M) Net assets 203 ($3.1M)
'17'18'19'20'21'22'23'24
Revenue (152)Expenses (184)Net assets (203)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2018 to 2019, from $2.0M to $2.7M (+41%).

$1.5M
$2.0M
$2.7M
$3.2M
$3.9M
$3.4M
$3.6M
$3.4M
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2020 6%. Grants only. Government contracts and fees sit inside program revenue.

89% of HIRSHBERG FOUNDATION FOR PANCREATIC CANC’s revenue is contributions — more donation-reliant than the typical peer (82% for the typical peer).

This organization
Typical peer · 3,053 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.

$165k
’17
$417k
’18
$791k
’19
$428k
’20
$679k
’21
−$231k
’22
−$209k
’23
−$295k
’24
2.0
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Lisa Manheim

Chief executive officer, director

As listed on its FY2024 Form 990.

'17'18'19'20'21'22'23'24
Listed44448777
Joined·+0+0+0+5+1+0+0
No longer listed·0001200
03Who funds it

Who funds it, year by year

2017 → 2023: the base broadened from 16 funders to 23 funders, grant income rose $198k → $406k.

18 of 83 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 59% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of HIRSHBERG FOUNDATION FOR PANCREATIC CANC’s funders (the co-funder graph). Top 30 of 83 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

HIRSHBERG FOUNDATION FOR PANCREATIC CANC has a broad base — no single funder exceeds 29% of grant income, and it takes 3 funders to reach half.

the vertical line marks half of all grant income — 3 funders to its left

66% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund HIRSHBERG FOUNDATION FOR PANCREATIC CANC.

29%
largest funder
55%
top three
~8
effective funders

Largest funder’s share by year: 2017 26% · 2018 38% · 2019 33% · 2020 55% · 2021 60% · 2022 22% · 2023 25% — broadly stable.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

27% of HIRSHBERG FOUNDATION FOR PANCREATIC CANC's funders are still giving 3 years after their first grant; 39% give in more than one year at all.

first grant+1y+2y+3y+4y+5y+6y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

59% of HIRSHBERG FOUNDATION FOR PANCREATIC CANC's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $1.3M that is directly attributable, 89% of it comes from California funders.

WA
MN
IL
NY
MA
OH
PA
NJ
CT
RI
CA
CO
MO
VA
DE
AZ
NC
TX
FL

In-state vs out-of-state, by year

’17
’18
’19
’20
’21
’22
’23
California out of state home

Funder states come from each funder’s own filing. $1.9M arriving through sponsors registered in 12 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

HIRSHBERG FOUNDATION FOR PANCREATIC CANC's revenue grew 52% between 2017 and 2024.

Operating margin−11% · bottom quartile
Months of reserve2.0mo · bottom quartile
Revenue growth (annualized)6% · below the median

this organization peer median middle 50% of peers· 2,910 philanthropy nonprofits $1M–$10M, FY2024

Organizations like HIRSHBERG FOUNDATION FOR PANCREATIC CANC

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In California

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

70% of spending goes to programs.

Program 70%Management 17%Fundraising 12%

Governance

7
board members
86%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

89%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 1 state

CA

Screen this organization

A dated, signed PDF of the compliance screen for HIRSHBERG FOUNDATION FOR PANCREATIC CANC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds HIRSHBERG FOUNDATION FOR PANCREATIC CANC?
HIRSHBERG FOUNDATION FOR PANCREATIC CANC (California) receives grants from 83 organizations whose IRS filings report $3,284,603 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($947,060). 32 of them have funded it in more than one year, and 59% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does HIRSHBERG FOUNDATION FOR PANCREATIC CANC have?
IRS filings report 83 organizations giving $3,284,603 in grants to HIRSHBERG FOUNDATION FOR PANCREATIC CANC, 32 of which have funded it in more than one year.
Who is the largest funder of HIRSHBERG FOUNDATION FOR PANCREATIC CANC?
FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $947,060 in grants. The full list of funders is on this page.
How can an organization like HIRSHBERG FOUNDATION FOR PANCREATIC CANC find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 83 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing